Session Information
2008 Midyear Clinical Meeting
Click here to go to the previous page
Oncology Pharmacy Specialty Sessions 2008: Advanced Topics in Practice, Part II
Track:
Educational Sessions
Program Code: 225-L01
Date: Tuesday, December 9, 2008
Time: 2:00 PM to 5:00 PM EST
Location:
S230H
MEETING PLANNING ASSOCIATE:
Dr. Mark Geraci, PharmD, BCOP, Pharmacy Benefits Management Strategic Healthcare Group (119D)
PRESENTER(S):
Christopher Fausel
Dr. Mark Geraci, PharmD, BCOP, Pharmacy Benefits Management Strategic Healthcare Group (119D)
LEARNER OUTCOMES:
- Describe controversial therapeutic dilemmas in caring for patients with adbanced illness.
- Differentiate between levels of hospice care and reimbursement levels throughout the United States.
- Discuss current care of head and neck cancer patients.
- Explain the current FDA opinion on the use of patient reported outcomes in the drug approval process.
- Outline the U.S. Food and Drug Administration's (FDA) requirements for accelerated drug approval for oncology products.